- Last sale
- Nov 12, 2026 · +0.06%
- Market cap
- —
- no share count on file
- Filings
- 1,080
FY 2025+4.1% FY25 yoy
FY 2025+122.0% FY25 yoy
FY 2025+97.3% FY25 yoy
FY 2025derived+24.0% FY25 yoy
FY 2025+123.2% FY25 yoy
FY 2025−12.2% FY25 yoy
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | £32,667,000,000 | reported | |
| FY 2024 | 2024-12-31 | £31,376,000,000 | reported | |
| FY 2023 | 2023-12-31 | £30,328,000,000 | reported | |
| FY 2022 | 2022-12-31 | £29,324,000,000 | reported | |
| FY 2021 | 2021-12-31 | £24,696,000,000 revised | reported | |
| FY 2020 | 2020-12-31 | £24,354,000,000 revised | reported | |
| FY 2019 | 2019-12-31 | £33,754,000,000 | reported | |
| FY 2018 | 2018-12-31 | £30,821,000,000 | reported | |
| FY 2017 | 2017-12-31 | £30,186,000,000 | reported | |
| FY 2016 | 2016-12-31 | £27,889,000,000 | reported | |
| FY 2015 | 2015-12-31 | £23,923,000,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | £2.56B | £1.38B | £3.94B | $0.66 | 4.32B sh | +0.0% | 61.6% |
| FY2024 | £2.44B | £0.00 | £2.44B | $0.61 | 4.31B sh | +0.1% | 47.4% |
| FY2023 | £2.25B | £0.00 | £2.25B | $0.58 | 4.31B sh | +0.0% | 41.2% |
| FY2022 | £3.47B | — | £3.47B | $0.61 | 4.31B sh | −20.0% | 55.4% |
| FY2021 | £4.00B | — | £4.00B | $1.00 | 5.39B sh | +0.0% | 57.1% |
Segments
LineFY2023ShareChange
Commercial Operations£30.33B100%+3.4%
Consumer Healthcare———
Pharmaceuticals———
Vaccines———
Total£30.33B
Pharmaceutical preparations
553 covered companies are filed under this code. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
JNJJohnson & Johnson$94.2B6.0%28.5%$682.6BLLYEli Lilly & Co$65.2B44.7%31.7%$1.3TMRKMerck & Co., Inc.$65.0B1.3%28.1%$362.3BPFEPfizer Inc$62.6B1.6%12.4%$164.3BABBVAbbVie Inc.$61.2B8.6%6.9%$520.5BAZNAstraZeneca PLC$58.7B8.6%17.4%—BMYBristol Myers Squibb Co$48.2B0.2%14.6%$127.4BABTAbbott Laboratories$44.3B5.7%14.7%$185.8B
GSKGSK PLC (this company)————
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, largest by revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
GSK PLC · CIK 1131399 · Engraved from SEC EDGAR